Search Results for 'Regenerative Medicine'

REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.

Thirty-seven Fulbright Awardees were officially announced at an event on MS The World, which was sponsored by a US Fulbright alumnus, Dr Jack Pinkowski and his wife Monica Pinkowski, as part of The Gathering on July 12. Since 1957, the Fulbright Awards are given annually by the Irish and US governments and provide Irish students, scholars, and professionals with the opportunity to study, lecture, and research at top universities and institutions throughout the United States.

John O’Dea, CEO of Galway-based Crospon and new president of Engineers Ireland, has said that the health of Ireland’s €7.9 billion medical devices export sector is hugely dependent on the expertise and ready supply of skilled engineers.

Scientists at the Regenerative Medicine Institute (REMEDI) in NUI Galway have teamed up with the TCD autism research group to discover how stem cell technology can help further the understanding of autism and perhaps lead to the development of better treatments.

NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.

Ireland has the capacity to be an international centre for commercialisation in the field of regenerative medicine, delegates at an international stem cell conference in NUI Galway heard this week.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.

Director of REMEDI, Professor Timothy O’Brien, is Head of Medicine at NUI Galway and a consultant endocrinologist at Galway University Hospital. REMEDI is one of Ireland’s top biomedical research institutes.